NCT01404598View on ClinicalTrials.gov

Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Pharmacokinetics
Interventions
DRUG

naproxcinod 750 bid

naproxcinod 750 bid

DRUG

naproxcinod 3000 mg od

naproxcinod 3000 mg od

DRUG

naproxen 500 mg bid

naproxen 500 mg bid

Sponsors

Lead Sponsor

NicOx
All Listed Sponsors
lead

NicOx

INDUSTRY